+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05984576

Study of Radiotherapy and Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Patients Previously Treated with Radiation A Multi-Center Observational Study by the Italian Association for Radiotherapy and Clinical Oncology

Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2023-08-09

88

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying recurrent rectal cancer in patients who have already received radiation therapy to the pelvic area. The study focuses on evaluating different types of radiotherapy, including reirradiation, and chemotherapy intensification to improve outcomes after local recurrence. This research aims to understand how combining surgery, chemotherapy, and advanced radiotherapy techniques can better control the cancer while considering previous treatments and patient condition. The study observes patients receiving reirradiation treatments using modern methods like volumetric modulated arc therapy VMAT, stereotactic body radiotherapy SBRT, proton therapy, and carbon ion radiotherapy. Total Neoadjuvant Therapy, which involves chemotherapy before surgery, is also considered. The study is observational and multi-center, allowing careful stratification to select appropriate therapies based on the recurrence type and clinical status. Participants will be monitored for their response to treatment and local cancer control over an eight-year period. Researchers will collect clinical data, imaging, and treatment details, ensuring participants meet specific health and functional criteria. The study will assess outcomes such as local control of the cancer and monitor safety and compliance throughout the follow-up, which may extend up to eight years after treatment.

CONDITIONS

Brief Title

Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Previously Irradiated Patients, an Italian Association for Radiotherapy and Clinical Oncology (AIRO)-GI Platform: a Multi-centre Prospective Observational Study

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here